The Role of Irisin in Initiating Resorption During the Skeletal Response to Exercise
鸢尾素在骨骼运动反应过程中启动吸收的作用
基本信息
- 批准号:10572067
- 负责人:
- 金额:$ 12.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-01 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Irisin is a novel signaling peptide proteolyzed from the cell membrane-bound protein Fndc5 (fibronectin type III
domain-containing protein 5), first described by our collaborators to release from muscle during exercise and
induce a thermogenic program in beige adipose tissue. A growing body of work has highlighted another key
role for irisin in mediating the effect of exercise on bone. Early work described an anabolic action, with
intermittent low doses of irisin stimulating cortical bone formation and preventing unloading-induced bone loss
in vivo, and serum-derived irisin from exercised mice enhancing osteoblastogenesis in vitro. Our group has
employed a genetic approach to further elucidate the role of irisin in skeletal remodeling, demonstrating that
forced expression of Fndc5 in muscle markedly reduced bone formation and osteoblast numbers while
increasing sclerostin (SOST) expression and osteoclast numbers. Global genetic deletion of Fndc5 conferred
complete protection against ovariectomy-induced bone loss, marked by maintenance of osteocyte lacunae and
blocked bone resorption with no increases in Receptor Activator of Nuclear Factor Kappa-β Ligand (RANKL)
expression despite prolonged estrogen deprivation. Similarly, short term irisin infusions in wild type mice
resulted in higher serum levels of sclerostin and RANKL. These results highlight the breadth of irisin’s signaling
effects in bone, and the need to further understand its overall impact on resorption and remodelling. We now
have additional evidence that irisin signals directly to the osteoclast via integrin αVβ5, stimulating differentiation
and resorption. The present work endeavors to delineate the full signaling pathway in the osteoclast, while
employing novel in vivo models to test this regulation of resorption in the context of skeletal response to
exercise. We have developed a novel conditional mouse allele of Fndc5 and generated a skeletal muscle-
specific targeted null, which we will use to test the effect of muscle-derived irisin on bone response to exercise.
In parallel, we will utilize in vitro techniques to confirm the putative receptors for irisin and characterize
intracellular signal transduction in the osteoclast. To comprehensively assess irisin’s impact on bone
resorption, we will also investigate indirect effects of irisin on the osteoclast, through regulation by the
osteocyte. Finally, as osteocyte response to mechanical cues is a key aspect of this cell’s function during
exercise, we will investigate the potential interplay between irisin signaling and mechanosensitivity. We predict
pleiotropic effects of irisin – it may be a coupling factor by directly stimulating both the osteoblast and
osteoclast, and also serve a unique role as a counter regulatory hormone to maintain calcium homeostasis by
increasing resorption. By focusing on the osteoclast, this work seeks to elucidate irisin’s role in initiating bone
resorption and better understand its influence on remodeling as a whole. Such insights both provide a greater
understanding of skeletal response to exercise but inform efforts to address bone degenerative diseases by
taking advantage of native signaling pathways.
虹膜蛋白是一种从细胞膜结合的蛋白FNDC5(纤连蛋白III型)的新型信号肽蛋白水解
含域的蛋白质5),首先由我们的合作者描述,是在运动期间从肌肉中释放出来的
在米色脂肪组织中诱导热程序。越来越多的工作突出了另一个钥匙
虹膜蛋白在介导运动对骨骼的影响中的作用。早期工作描述了合成代谢作用,
间歇性低剂量的虹膜蛋白刺激皮质骨形成并防止卸载引起的骨质流失
体内和来自运动小鼠的血清衍生的虹膜蛋白在体外增强成骨细胞生成。我们的小组有
采用一种遗传方法来进一步阐明虹膜蛋白在骨骼重塑中的作用,表明
FNDC5在肌肉中的强迫表达显着降低了骨形成和成骨细胞数量
增加硬化素(SOST)表达和破骨细胞数。 FNDC5的全球遗传缺失
完全保护卵巢切除术引起的骨质损失,以维持骨细胞腔和
骨骼分辨率阻塞,核因子Kappa-β配体(RANKL)的受体激活剂无增加
表达延长雌激素剥夺。同样,野生型小鼠的短期虹膜蛋白输注
导致较高的血清硬化蛋白和RANKL水平。这些结果突出了虹膜信号传导的广度
对骨骼的影响,以及进一步了解其对分辨率和重塑的总体影响的需求。我们现在
还有其他证据表明虹膜蛋白通过整合素αVβ直接向破骨细胞信号,刺激分化
和解决方案。目前的工作努力描绘破骨细胞中的完整信号通路,而
采用新颖的体内模型在骨骼反应的背景下测试该分辨率的调节
锻炼。我们已经开发了一个新型的有条件小鼠的FNDC5等位基因,并产生了骨骼肌 -
特定的靶向零,我们将用来测试肌肉衍生的虹膜蛋白对运动骨反应的影响。
同时,我们将利用体外技术来确认虹膜蛋白的假定受体并表征
破骨细胞中的细胞内信号转导。全面评估虹膜蛋白对骨骼的影响
解决方案,我们还将通过通过调节来调查虹膜蛋白对破骨细胞的间接影响
骨细胞。最后,由于骨细胞对机械提示的响应是该单元格期间该单元功能的关键方面
练习,我们将研究虹膜蛋白信号传导和机械敏感性之间的潜在相互作用。我们预测
虹膜蛋白的多效作用 - 它可能是直接刺激成骨细胞和成骨细胞和
破骨细胞,还扮演着一个独特的角色,作为计数器调节骑马,可维持钙稳态
增加分辨率。通过专注于破骨细胞,这项工作旨在阐明艾里森在发起骨骼中的作用
解决方案并更好地了解其对整个重塑的影响。这些见解都提供了更大的
理解骨骼对运动的反应,但可以为解决骨骼退化性疾病的努力提供信息
利用天然信号通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Eben Grant Estell的其他基金
The Myokine Irisin Modulates Bone Resorption via Stimulation of Osteoclastogenesis
肌动素鸢尾素通过刺激破骨细胞生成调节骨吸收
- 批准号:1022855610228556
- 财政年份:2020
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
The Myokine Irisin Modulates Bone Resorption via Stimulation of Osteoclastogenesis
肌动素鸢尾素通过刺激破骨细胞生成调节骨吸收
- 批准号:1042613010426130
- 财政年份:2020
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
相似国自然基金
新型BPA替代品BPSIP生命早期暴露对子代脂肪组织发育的影响及表观遗传机制
- 批准号:22306173
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
肥胖脂肪组织小囊泡转运鞘磷脂调控鞘磷脂水解代谢促进破骨分化影响骨质疏松的机制研究
- 批准号:32300985
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ANGPTLs基因及其蛋白表达水平调控内脏脂肪组织影响健康衰老表型的前瞻性队列研究
- 批准号:82373661
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂肪组织中SIRT3通过抑制外泌体miR-30a-3p调控肝脏自噬影响非酒精性脂肪肝病的机制研究
- 批准号:32360174
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
FTL+ALB+脂肪干细胞与CD36+EBF2-内皮细胞通过交互作用影响脂肪组织衰老的机制研究
- 批准号:82370884
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:1067440110674401
- 财政年份:2023
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
The Role of Fat in Osteoarthritis
脂肪在骨关节炎中的作用
- 批准号:1086668710866687
- 财政年份:2023
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:1073511710735117
- 财政年份:2023
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
Impact of Per/Polyfluoroalkyl pollutants on vascular disease mechanisms
全氟烷基/多氟烷基污染物对血管疾病机制的影响
- 批准号:1075123910751239
- 财政年份:2023
- 资助金额:$ 12.74万$ 12.74万
- 项目类别:
Age-Dependent N-Glycosylation of Follicle-Stimulation Hormone in Gonadotropes
促性腺激素中卵泡刺激激素的年龄依赖性 N-糖基化
- 批准号:1067925410679254
- 财政年份:2023
- 资助金额:$ 12.74万$ 12.74万
- 项目类别: